A clinical study of KDT-3594 in Japanese patients with early Parkinson's disease.
Phase 2
- Conditions
- Parkinson's disease
- Registration Number
- JPRN-jRCT2031210089
- Lead Sponsor
- Shimizu Yoshitaka
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 6
Inclusion Criteria
Patients who are diagnosed with Parkinson's disease according to UK Parkinson's Disease society brain bank clinical diagnostic criteria
-Patients with Parkinson's disease in Stages 1 to 3 on the Modified Hoehn and Yahr Scale
Exclusion Criteria
-Patients who are suspected any parkinsonism except for idiopathic Parkinson's disease.
-Patients who underwent neurosurgical medical treatment (stereotaxic destruction, deep brain stimulation etc.) for PD, or patients for whom surgical treatment is scheduled during the study
-Patients with a complication of obvious dementia, or patients with Mini-Mental State Examination (MMSE) score < 24 points
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method